Role of routine 16b1 lymph node biopsy in the management of gallbladder cancer: an analysis  by Agarwal, Anil K. et al.
ORIGINAL ARTICLE
Role of routine 16b1 lymph node biopsy in the management of
gallbladder cancer: an analysis
Anil K. Agarwal, Raja Kalayarasan, Amit Javed & Puja Sakhuja
Department of Gastrointestinal Surgery and Pathology, Govind Ballabh Pant Hospital and Maulana Azad Medical College, Delhi University, New Delhi, India
Abstract
Background: Involvement of the 16b1 (interaortocaval) lymph node (LN) in gallbladder cancer (GBC) is
considered to represent metastatic disease. Although this is universally accepted, the role of routine
frozen-section histopathological examination (HPE) of the 16b1 LN in the management of GBC has not
been previously reported.
Methods: A prospective study (August 2009–November 2011) using routine biopsy of 16b1 LNs and
frozen-section HPE prior to radical resection in patients deemed operable on preoperative evaluation and
staging laparoscopy was carried out.
Results: Of the 451 GBC patients assessed, 251 (55.7%) were deemed operable on preoperative
imaging. Of these, 68 (27.1%) were found to have disseminated disease on staging laparoscopy/
laparotomy. Of the 183 patients in whom 16b1 LN biopsy was performed, 34 (18.6%) had evidence of
metastases on frozen-section HPE and the planned surgical resection was abandoned (Group A). Of the
remaining 149 patients (Group B), 142 (95.3%) underwent curative resection and seven (4.7%) were found
to be unresectable as a result of locoregionally advanced disease. A comparison of findings in Group A
with those in Group B showed no significant difference in the clinical stage of the tumour. The proportions
of patients with jaundice, elevated carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9
levels were significantly higher in Group A than in Group B (P = 0.008, P = 0.012 and P = 0.023,
respectively).
Conclusions: Routine 16b1 LN biopsy prevented non-therapeutic radical resection and its associated
morbidity in 18.6% of patients deemed resectable on preoperative imaging and staging laparoscopy. The
yield was higher in patients with jaundice and elevated preoperative tumour marker levels.
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Introduction
Interaortocaval (16b1) lymph node (LN) involvement in gallblad-
der cancer (GBC) is a sign of advanced disease with a dismal
prognosis equivalent to that of distant metastases.1–6 Hence, accu-
rate preoperative assessment of the 16b1 LN is crucial in optimiz-
ing the management of patients with GBC. Although the
morphological appearance (size >10 mm and heterogeneous
internal architecture) of the 16b1 LN on computed tomography
(CT) of the abdomen has been reported to be useful in predicting
metastatic involvement in some studies, others have not found
these factors to be good predictors of metastatic disease.7–9 Given
the poor positive predictive value of cross-sectional imaging for
detection of 16b1 LNs, intraoperative biopsy and frozen-section
analysis of these nodes have been proposed.7,8 However, the
impact of routine 16b1 LN biopsy on the surgical management of
GBC has not been studied previously.
The aim of this study was to prospectively analyse the role of
routine 16b1 LN biopsy and frozen-section histopathological
examination (HPE) prior to radical surgery for GBC at a high-
volume institution.
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Materials and methods
This was a prospective study performed over a period of 28
months from August 2009 to November 2011. All patients sus-
pected to have GBC and without evidence of distant metastases on
clinical evaluation underwent ultrasound (US) examination of
the abdomen. Patients without evidence of dissemination subse-
quently underwent dual-phase CT of the abdomen. Magnetic
resonance cholangiopancreatography (MRCP) was carried out
selectively in patients presenting with jaundice. Patients with inci-
dental GBC (T-stage Ib or higher) underwent a similar staging
workup. If preoperative imaging revealed an enlarged 16b1 LN
(defined by a size >10 mm along the short axis or heterogeneous
internal architecture), image-guided fine needle aspiration cytol-
ogy (FNAC) was performed to confirm the diagnosis.9 Metastatic
involvement of a 16b1 LN was considered to indicate advanced
inoperable disease and only palliative treatment was offered.
Levels of serum tumour markers [carcinoembryonic antigen
(CEA) and carbohydrate antigen (CA) 19-9] were obtained and
tumours were staged according to the tumour–node–metastasis
(TNM) method for staging GBC outlined by the American Joint
Committee on Cancer.10
Patients with potentially resectable tumours on preoperative
imaging underwent a staging laparoscopy (SL) as previously
described.11 Patients with an enlarged 16b1 LN on preoperative
imaging and in whom image-guided FNAC was not possible or
was negative proceeded to surgery. Patients without evidence of
metastatic disease on SL underwent laparotomy. A thorough
evaluation for evidence of occult liver and peritoneal metastases
was performed; positive findings were confirmed by frozen-
section HPE. Before proceeding with radical resection, routine
biopsy of the 16b1 LN was performed. Duodenal kocherization
was performed to adequately expose the interaortocaval area. All
LNs in the interaortocaval region below the level of the left renal
vein were excised and sent for frozen-section examination.
Lymph nodes sent for frozen-section examination were counted
and dissected by the pathologist. Each LN was bisected and
processed whole. Three frozen sections from each LN were
examined after haematoxylin and eosin staining for the presence
of metastases. A 16b1 LN found to be positive for disease on
frozen-section analysis was considered to indicate metastatic
disease and the planned surgical resection was abandoned. Pal-
liative procedures were performed if indicated. In patients with
resectable disease, the type of resection performed was deter-
mined by the locoregional extent of the tumour (i.e. liver and
adjacent organ infiltration).12
Clinicopathological features in patients with 16b1 LN metas-
tases (Group A) were compared with those in patients without
16b1 LN metastases (Group B) to determine factors predictive of
16b1 LN metastases. For the purpose of this analysis, early GBC
was defined by the clinical presence of stage T1 or T2 tumours
irrespective of LN involvement; stage T3 and T4 tumours were
classified as indicating locally advanced disease. Clinical staging
rather than pathological staging was used because a final his-
topathological confirmation of the T-stage was not available in
patients found to have 16b1 LN metastases.
Statistical analysis was performed using GraphPad instat
Version 4 (GraphPad Software, Inc., La Jolla, CA, USA). Median
values were compared using the Mann–Whitney test. Proportions
were compared using Fisher’s exact test. A P-value of <0.05 was
considered to indicate statistical significance.
Results
During the study period, 451 patients with GBC were assessed for
operability (Fig. 1). Of these, 183 (40.6%) patients underwent
intraoperative biopsy followed by frozen-section examination of
16b1 LNs. The median number of 16b1 nodes sampled was three
(range: one to six). Resection of the tumour was not performed in
34 (18.6%) patients with evidence of 16b1 nodal metastases on
frozen-section examination (Group A). This was subsequently
confirmed in a final HPE by paraffin section in all patients; there
were no false positive results in frozen-section examination. Of
the remaining 149 (81.4%) patients without evidence of metas-
tases on frozen-section examination of 16b1 LNs (Group B), 142
(95.3%) underwent curative resection and seven (4.7%) were
found to be unresectable as a result of locoregionally advanced
disease.
The median age of patients in Group A was 54 years (range:
23–66 years) and the majority were female (female : male ratio:
2.1:1). There was no significant difference between Groups A and
B in the age and gender distribution of patients (P = 0.128 and
P = 0.282, respectively). Of the 183 patients, 25 (13.7%) had early
GBC and the other 158 (86.3%) had locally advanced disease.
Jaundice was identified in 29 (15.8%) patients and gastric outlet
obstruction in nine (4.9%) patients. There was no significant
difference between the groups in prevalences of abdominal pain,
weight loss, vomiting and palpable gallbladder mass (P = 1.000,
P = 0.098, P = 0.063 and P = 0.343, respectively). The proportion
of patients with jaundice was significantly higher in Group A than
in Group B (P = 0.008) (Table 1). Twenty-six (76.5%) patients in
Group A had elevated tumour marker levels (CEA and CA 19-9)
compared with 81 (54.4%) in Group B (P = 0.021).
Of the 183 patients, 15 (8.2%) fulfilled the radiological criteria
suggestive of 16b1 LN metastases (Table 2). The sensitivity and
positive predictive value of these radiological criteria to detect
16b1 LN metastases were 14.7% and 33.3%, respectively. Image-
guided FNAC of enlarged 16b1 LNs showed a false negative rate of
30% (Table 2). The radiological criteria used to identify 16b1 LN
metastases were applied for LNs in stations 8, 9, 12, 13 and 14 to
determine whether these enlarged proximal LNs correlated with
16b1 LN metastases. Although the proportion of patients with
proximal LN metastases was higher in Group A (79.4%, 27 of 34
patients) than in Group B (65.8%, 98 of 149 patients), the differ-
ence was not statistically significant (P = 0.154).
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Figure 1 Flow chart showing the process of evaluation in 451 gallbladder cancer (GBC) patients assessed for operability during the period
from August 2009 to November 2011. FNAC, fine needle aspiration cytology
Table 1 Clinicopathological characteristics in gallbladder cancer (GBC) patients with 16b1 lymph node (LN) metastases (Group A) and






Clinical stage, n (%)
Early GBC 2 (5.9%) 23 (15.4%)
0.175
Locally advanced GBC 32 (94.1%) 126 (84.6%)
Jaundice 11 (32.4%) 18 (12.1%) 0.008
Gastric outlet obstruction 4 (11.8%) 5 (3.4%) 0.063
Incidental GBC, n (%)
Stage T1b – 6 (4.0%)
1.000
Stages T2 and T3 2 (5.9%) 23 (15.4%)
Tumour markers
CEA, ng/ml, median (range) 21.7 (2.3–189) 10.6 (2.7–105) 0.012
CA 19-9, U/ml, median (range) 181.5 (10.3–1081) 79.3 (12.6–313) 0.023
CEA, carcinoembryonic antigen; CA 19-9, carbohydrate antigen 19-9.
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Discussion
Gallbladder cancer is characterized by early LN metastases; overall
45–85% of patients with GBC have LN involvement.1,2,13 The col-
lecting trunks from the lymphatic plexuses in the wall of the
gallbladder terminate in the cystic and pericholedochal LNs and
follow one of three pathways to converge at the 16b1 LN in the
interaortocaval location (Fig. 2).14 Although this is the most
common arrangement of lymphatic spread from the gallbladder,
extensive connections exist between the various lymphatic chan-
nels, including a direct spread to the 16b1 node from the peric-
holedochal node. However, the 16b1 node is considered as the
final abdominal nodal station for GBC and from here tumour
cells enter the systemic circulation through the thoracic duct.14
Although extended lymphadenectomy (including para-aortic
lymphadenectomy) was recommended to achieve longterm cure
in some early reports, Kondo et al. and others reported that
patients with 16b1 LN metastases had poor survival similar to that
in patients with hepatic or peritoneal metastases.4–6,15 Hence,
although intraoperative biopsy and frozen-section analysis of the
16b1 node before radical surgery have been proposed by various
authors,7,8 the impact of routine 16b1 LN biopsy on the surgical
management of GBC has not been analysed previously.
Preoperative assessment of 16b1 LN metastases is essential to
prevent non-therapeutic surgical exploration and resection. The
criteria proposed as diagnostic of metastatic LN involvement on
CT of the abdomen are: size of >10 mm; a round shape, and
a heterogeneous internal architecture.9 The poor sensitivity
(14.7%) and positive predictive value (33.3%) reported in the
present series highlight the fact that a significant number of
patients without these radiological characteristics were found to
have 16b1 LN metastatic involvement; this is consistent with
previous reports.7,16 Although 18FDG-positron emission tomog-
raphy (PET) has been used to identify metastatic LNs in patients
with biliary cancer, its sensitivity is low.17 High-resolution mag-
netic resonance imaging (MRI) using lymphotropic superpara-
magnetic nanoparticles has been shown to detect metastatic LNs
of <5 mm in diameter in prostate cancer.18 However, its role in
evaluating LN involvement in GBC remains to be determined.
As current imaging modalities are less accurate in detect-
ing 16b1 LN metastases, histopathological confirmation is
essential.
Histological confirmation can be obtained preoperatively
through image-guided (using US or CT) FNAC of the enlarged
16b1 LN. However, as in the present study, image-guided FNAC
may not be possible in all patients. The absence of a safe window
as a result of adjacent vessels is the most common cause of
technical failure. Percutaneous image-guided FNAC was found
to have a false negative rate of 30% in the present series. Possible
reasons for this include failure to target the metastatic node
and inadequate aspiration. This highlights the importance of
intraoperative 16b1 LN biopsy and frozen-section examina-
tion, even in patients without evidence of metastases on per-
cutaneous image-guided FNAC. In the present series, which
represents the largest prospective study to analyse the role of
routine 16b1 LN biopsy in GBC reported to date, radical surgery
was found to be avoidable in 18.6% of patients with potentially
resectable tumours on preoperative evaluation. The majority
(94.1%) of patients with 16b1 LN metastases had locally
advanced tumours (clinical stages T3 and T4). However, 16b1
LN involvement was also present in two (8%) patients with early
GBC (clinical stages T1 and T2). These findings suggest that
although the yield of routine 16b1 LN biopsy is low in stage
T1 and T2 tumours, it may still have a role. In the present
study, GBC patients with jaundice secondary to bile duct infil-
tration had a higher incidence of 16b1 LN metastases. Although
skip metastases to the 16b1 LN can occur, in the present study
all 34 patients with 16b1 LN metastases also had enlarged
regional LNs. Because surgical resection was not performed in
patients with 16b1 LN metastases, histological confirmation of
regional LN involvement could not be obtained. Recently, biop-
sies of regional LNs in patients with 16b1 LN metastases have
been performed to ascertain the incidence of skip metastases.
However, in the study by Kondo et al., all patients with 16b1 LN
metastases (n = 23) were also found to have regional LN metas-
tases, which suggests that skip metastases to the 16b1 LN are
rare.6
Nanashima et al. assessed the utility of combining CT findings
and serum CA 19-9 levels in the diagnosis of LN metastases and
reported raised CA 19-9 levels in the absence of typical CT find-
ings of a metastatic 16b1 LN in nine of 20 patients with 16b1 LN
metastases.19 In the present study, patients with 16b1 LN metas-
tases had significantly higher tumour marker (CEA and CA
19-9) levels, which suggests that elevated levels of tumour
markers may help to predict 16b1 LN metastases in patients with
potentially resectable disease on preoperative evaluation. Future
strategies should seek to improve preoperative detection and to
avoid non-therapeutic laparotomy secondary to 16b1 LN metas-
tases. Endoscopic US (EUS) is a promising method of assessing
the 16b1 LN and of performing image-guided FNAC.19 However,
there are no studies on the role of EUS-guided FNAC in detect-
ing 16b1 LN metastases in GBC and a prospective study is cur-
rently underway to ascertain whether the addition of EUS (with
guided FNAC in patients with enlarged nodes) could obviate
false negative results associated with percutaneous FNAC.
Table 2 Outcomes of fine needle aspiration cytology (FNAC) in
gallbladder cancer patients in whom enlarged 16b1 lymph nodes





Image-guided FNAC technically not feasible,
n = 5
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Staging laparoscopy has high sensitivity for detecting surface
liver and peritoneal metastases; however, it is generally not used
as a tool for detecting nodal metastases.11 Laparoscopic 16b1 LN
biopsy as part of SL has been performed recently in selected
patients and has the potential to improve the yield of SL and
obviate non-therapeutic laparotomy.
Conclusions
Routine 16b1 LN biopsy avoided radical surgery in 18.6% of
patients with potentially resectable GBC after preoperative evalu-
ation. The yield of 16b1 LN biopsy was higher in patients with


























CBD − Common bile duct
PV − Portal vein
HA − Hepatic artery
LGA − Left gastric artery
CA − Coeliac artery
SMA − Superior mesenteric artery
IMA − Inferior mesenteric artery
LRV − Left renal vein
IVC − Inferior vena cava
8 − Common hepatic artery LN













9 − Coeliac LN
12 − Along hepatoduodenal
       ligament
12a − Proper hepatic artery LN









12c − Cystic LN
12p − Retroportal LN
12h − Hilar LN
13 − Posterior superior
       pancreaticoduodenal LN
14 − Superior mesenteric
       artery LN
16b1 − Para-aortic LN between
           left renal vein and
           inferior mesenteric artery
a
b
Figure 2 The collecting trunks from the lymphatic plexuses in the gallbladder wall terminate in the cystic and pericholedochal lymph nodes
(LNs) and follow one of three pathways to converge at the 16b1 LN in the interaortocaval location
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tumour marker levels. Whether the addition of EUS and laparo-
scopic 16b1 LN biopsy can improve detection and obviate non-
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